Cargando…
Apelin Is a Prototype of Novel Drugs for the Treatment of Acute Myocardial Infarction and Adverse Myocardial Remodeling
In-hospital mortality in patients with ST-segment elevation myocardial infarction (STEMI) is 5–6%. Consequently, it is necessary to develop fundamentally novel drugs capable of reducing mortality in patients with acute myocardial infarction. Apelins could be the prototype for such drugs. Chronic adm...
Autores principales: | Popov, Sergey V., Maslov, Leonid N., Mukhomedzyanov, Alexandr V., Kurbatov, Boris K., Gorbunov, Alexandr S., Kilin, Michail, Azev, Viacheslav N., Khlestkina, Maria S., Sufianova, Galina Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056827/ https://www.ncbi.nlm.nih.gov/pubmed/36986889 http://dx.doi.org/10.3390/pharmaceutics15031029 |
Ejemplares similares
-
The Infarct-Reducing Effect of the δ(2) Opioid Receptor Agonist Deltorphin II: The Molecular Mechanism
por: Popov, Sergey V., et al.
Publicado: (2023) -
Pharmacological Approaches to Limit Ischemic and Reperfusion Injuries of the Heart: Analysis of Experimental and Clinical Data on P2Y(12) Receptor Antagonists
por: Maslov, Leonid N., et al.
Publicado: (2022) -
Do reactive oxygen species damage or protect the heart in ischemia and reperfusion? Analysis on experimental and clinical data
por: Maslov, Leonid N., et al.
Publicado: (2023) -
A historical literature review of coronary microvascular obstruction and intra-myocardial hemorrhage as functional/structural phenomena
por: Maslov, Leonid N., et al.
Publicado: (2023) -
δ-Opioid Receptor as a Molecular Target for Increasing Cardiac Resistance to Reperfusion in Drug Development
por: Naryzhnaya, Natalia V., et al.
Publicado: (2023)